2/4
09:00 am
txg
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
Low
Report
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
2/3
04:47 am
txg
1 Momentum Stock to Target This Week and 2 We Turn Down [Yahoo! Finance]
Low
Report
1 Momentum Stock to Target This Week and 2 We Turn Down [Yahoo! Finance]
1/27
02:29 pm
txg
10x Genomics (NASDAQ:TXG) had its price target lowered by analysts at Leerink Partners from $22.00 to $20.00. They now have a "market perform" rating on the stock.
Low
Report
10x Genomics (NASDAQ:TXG) had its price target lowered by analysts at Leerink Partners from $22.00 to $20.00. They now have a "market perform" rating on the stock.
1/22
04:05 pm
txg
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
Medium
Report
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
1/19
06:52 am
txg
3 Hyped Up Stocks That Concern Us [Yahoo! Finance]
Low
Report
3 Hyped Up Stocks That Concern Us [Yahoo! Finance]
1/12
09:26 am
txg
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease [Yahoo! Finance]
Medium
Report
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease [Yahoo! Finance]
1/12
09:11 am
txg
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
Medium
Report
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
1/12
09:10 am
txg
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
Medium
Report
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
1/12
09:00 am
txg
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
Medium
Report
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
1/12
08:42 am
txg
10x Genomics (NASDAQ:TXG) was given a new $21.00 price target on by analysts at Needham & Company LLC.
Medium
Report
10x Genomics (NASDAQ:TXG) was given a new $21.00 price target on by analysts at Needham & Company LLC.
1/11
12:00 pm
txg
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
Medium
Report
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
1/7
01:18 pm
txg
10x Genomics (NASDAQ:TXG) had its price target raised by analysts at TD Cowen from $15.00 to $18.00. They now have a "hold" rating on the stock.
Low
Report
10x Genomics (NASDAQ:TXG) had its price target raised by analysts at TD Cowen from $15.00 to $18.00. They now have a "hold" rating on the stock.
1/7
10:58 am
txg
10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at Cowen Inc.
Low
Report
10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at Cowen Inc.
1/2
07:01 pm
txg
2 Russell 2000 Stocks Worth Investigating and 1 We Avoid [Yahoo! Finance]
High
Report
2 Russell 2000 Stocks Worth Investigating and 1 We Avoid [Yahoo! Finance]
12/29
04:05 pm
txg
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/23
04:09 pm
txg
10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/22
10:37 pm
txg
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending [Yahoo! Finance]
Low
Report
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending [Yahoo! Finance]
12/22
08:02 am
txg
10x Genomics (NASDAQ:TXG) had its price target raised by analysts at Canaccord Genuity Group Inc. from $19.00 to $20.00. They now have a "buy" rating on the stock.
Medium
Report
10x Genomics (NASDAQ:TXG) had its price target raised by analysts at Canaccord Genuity Group Inc. from $19.00 to $20.00. They now have a "buy" rating on the stock.
12/15
07:02 am
txg
10x Genomics (NASDAQ:TXG) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
10x Genomics (NASDAQ:TXG) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/11
04:08 pm
txg
10x Genomics (NASDAQ:TXG) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "cautious" rating.
Medium
Report
10x Genomics (NASDAQ:TXG) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "cautious" rating.
12/11
08:43 am
txg
10x Genomics (NASDAQ:TXG) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
10x Genomics (NASDAQ:TXG) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
12/1
06:03 pm
txg
10x Genomics (NASDAQ:TXG) was given a new $20.00 price target on by analysts at Morgan Stanley.
Low
Report
10x Genomics (NASDAQ:TXG) was given a new $20.00 price target on by analysts at Morgan Stanley.
11/18
01:14 pm
txg
10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
09:00 am
txg
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
Low
Report
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
11/15
11:51 pm
txg
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch [Yahoo! Finance]
Neutral
Report
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch [Yahoo! Finance]